Dr. Ottheinz Krebs
Chief Operating Officer
Chief Operating Officer
Oryx Translational Medicine
Germany
Biography
Dr. Krebs is a biochemist and virologist with more than 10 years experience in preclinical and clinical research. Prior to joining ORYX in 2008, he held management positions at Genelux Corp. and Metriopharm AG. His tasks at Genelux included the development of recombinant vaccinia viruses for tumor therapy.
Research Interest
Biochemistry and Virology
